Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species
Katrien Lagrou(KU Leuven), Eric Van Wijngaerden(KU Leuven), T. Rijdt, Willy Peetermans(KU Leuven), Johan Maertens(Unknown), Jan Verhaegen(KU Leuven)
European Journal of Clinical Microbiology & Infectious Diseases
June 14, 2007
Cited by 52
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k